CRP and myocardial infarction: In hypercholesterolemic patients, atorvastatin withdrawal rapidly increases pro-inflammatory and pro-thrombotic pathways [130], while simvastatin withdrawal during an acute MI event has been associated with a rebound increase in CRP levels [131].